NM_016239.4:c.8225-12G>A
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_016239.4(MYO15A):c.8225-12G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000106 in 1,610,536 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_016239.4 intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152230Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000165 AC: 4AN: 242892Hom.: 0 AF XY: 0.00000756 AC XY: 1AN XY: 132228
GnomAD4 exome AF: 0.00000892 AC: 13AN: 1458188Hom.: 0 Cov.: 32 AF XY: 0.00000965 AC XY: 7AN XY: 725270
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152348Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74502
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.8225-12G>A variant in MYO15A has not been previously reported in individua ls with hearing loss, but was identified in 4/23348 African chromosomes by the G enome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs54 1139484). Although this variant has been seen in the general population, its fre quency is not high enough to rule out a pathogenic role. This variant is located in the 3' splice region. Computational tools suggest a possible impact to splic ing; however, this information is not predictive enough to determine pathogenici ty. In summary, the clinical significance of the c.8225-12G>A variant is uncerta in. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at